Home › Crohn's Disease › Florida
Pag-aaral pangklinika para sa Crohn's Disease sa Florida
26 pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
- Miami19 pag-aaral
- Orlando19 pag-aaral
- Tampa11 pag-aaral
- Spring Hill5 pag-aaral
- Kendall5 pag-aaral
- Jacksonville4 pag-aaral
- Hialeah4 pag-aaral
- Town 'n' Country3 pag-aaral
- Gainesville3 pag-aaral
- Lakeland3 pag-aaral
- Clearwater3 pag-aaral
- Naples3 pag-aaral
- Pensacola3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Study of SL-325 in Crohn's Disease Patients
- Clinical Trial Site, Inverness
- Clinical Trial Site, Kissimmee
- Clinical Trial Site, Naples
- at 2 pa
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07753850A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Covenant Metabolic Specialists, LLC ( Site 5150), Fort Myers
- Nature Coast Clinical Research - Inverness ( Site 5042), Inverness
- Sanchez Clinical Research ( Site 5144), Miami
- at 4 pa
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06430801A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07483073Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- at 3 pa
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06937099A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Bioresearch Partner-Kendale Lakes, Miami
- Endoscopic Research Inc, Orlando
- at 1 pa
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06226883A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07483099A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- American Institute of Research, Cutler Bay
- Nature Coast Clinical Research, Inverness
- Florida Research Center Inc., Lakewood Rch
- at 2 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07196722A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Florida Research Center Inc., Lakewood Rch
- Sanchez Clinical Research, Inc, Miami
- Endoscopic Research Inc, Orlando
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07577843A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Green Leaf Clinical Trials, Jacksonville
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
- at 3 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07499232A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- West Central Gastroenterology, LLP, d/b/a/ Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- Wellness Clinical Research, Miami Lakes
- at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06233461A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400017, Kissimmee
- Investigational Site Number: 8400015, Lighthouse PT
- Investigational Site Number 8400028, Miami
- at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06958536A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Access Research Institute, Brooksville
- Gastro Florida, Clearwater
- Digestive and Liver Center of Florida, P.A., Kissimmee
- at 5 pa
Nagre-recruitPhase 4
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Synergy Healthcare - Bradenton /ID# 284157, Bradenton
- Clinical Research of Osceola /ID# 280593, Kissimmee
- Florida Center For Gastroenterology - Largo /ID# 281059, Largo
- at 4 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07697456Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
- University of Miami, Miami
- Digestive & Liver Center of Florida, Orlando
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06997965A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
- at 2 pa
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07184944An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Novum Research, LLC-Site Number: 8400003, Clermont
- Sarkis Clinical Trials - Gainesville-Site Number: 8400048, Gainesville
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- at 12 pa
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT05995353Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Novum Research /ID# 278128, Clermont
- University of Florida College of Medicine /ID# 266930, Gainesville
- Nature Coast Clinical Research - Inverness /ID# 265874, Inverness
- at 9 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
- University of Miami, Miami
Nagre-recruit
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07671872Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Jacksonville, Jacksonville
- Advent Health, Orlando
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Miami, Miami
- AdventHealth, Orlando
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07237516Precise Infliximab Exposure and Pharmacodynamic Control
- Nemours Children's Health System-Jacksonville, Jacksonville
Nagre-recruitPhase 2/3
Edad 6 hanggang 22 · Lahat ng kasarian · Na-update May 5, 2026 · NCT05660746Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Clinical Research Of Brandon, LLC, Brandon
- West Central Gastroenterology d/b/a Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- at 7 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- at 3 pa
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
- Mayo Clinic Florida, Jacksonville
Nagre-recruit
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06647615Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Florida, Gainesville
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT06721962Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.